A new method for detecting metabolic diseases
Through the method of combining the micro-sampler and the copper superhydrophobic substrate, the lateral friction measurement is used to solve the problem of cumbersome detection and insufficient accuracy in metabolic disease detection, achieving high sensitivity and low cost detection effects.
Patent Information
- Application Number
- CN202211669212.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-24
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2042-12-24
AI Technical Summary
The existing metabolic disease detection methods have problems such as cumbersome detection, expensive equipment, insufficient accuracy and susceptible to interference, especially in urine and blood tests.
Using the method of combining micro-samplers and copper superhydrophobic substrates, the lateral friction force measurement of the droplets is measured, and the photoelectric position-sensitive detector and computer display the lateral friction force of the sample solution in real time, achieving high sensitivity to metabolic diseases. Test.
It simplifies the detection process, reduces costs, improves the accuracy and sensitivity of detection, and can quickly and accurately detect metabolic diseases, avoiding the problem of limited detection range.
Smart Images

Figure CN115791645B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to biological disease detection, and more particularly to a novel metabolic disease detection method. Background Art
[0002] As people's living standards improve, metabolic diseases are on the rise. Therefore, the detection of metabolic diseases has become a major concern in society. The primary methods for detecting metabolic diseases are blood tests and urine tests. However, urine tests are cumbersome, difficult to perform on emergency patients, and results are significantly affected by the operator and the environment. The equipment is expensive. Blood tests also suffer from issues such as low accuracy and susceptibility to interferences.
[0003] In the patent document with publication number CN111650314A, a new non-derivative method tandem mass spectrometry kit and method for detecting substances related to genetic metabolic diseases is disclosed. However, the tandem mass spectrometer has a complex structure and high maintenance costs. At the same time, the mass spectrometer is a high-precision instrument, and when used in the laboratory, it requires specially trained technical staff to operate the mass spectrometer. In the document "Study on the Influence of Droplet Sugar Content on the Wetting Properties of Superhydrophobic Surfaces", the authors also proposed to determine the patient's blood sugar level by comparing the sugar content parameters of the blood with the change pattern of the contact angle of the superhydrophobic surface. However, there are many factors in the contact angle measurement process, such as the roughness, uniformity, polarity, contamination, etc. of the solid surface. Although the surface of the test sample is guaranteed to be flat, there will be certain errors when the instrument or human adjusts the baseline measurement. Summary of the Invention
[0004] The present invention aims to overcome the deficiencies of the above-mentioned prior art and to provide a novel method for detecting metabolic diseases, so as to achieve high-sensitivity detection of metabolic diseases.
[0005] The present invention provides a novel method for detecting metabolic diseases, which is characterized by comprising:
[0006] First, a standard sample solution is prepared for calibration. A certain amount of the standard sample solution is slowly squeezed out using a microinjector. The droplet is then slowly dripped from the microinjector needle onto a super-hydrophobic copper substrate. The super-hydrophobic copper substrate begins to move under the action of an external force.
[0007] After the sample solution droplet contacts the free end of the capillary, the reflected light beam generated by the laser is received by a photoelectric position-sensitive detector. The data acquisition card displays the lateral friction force of different standard sample solution droplets in real time on the Lab VIEW program on the computer side, calibrating the relationship between different standard sample solutions and their lateral friction force.
[0008] Prepare a human sample solution to be tested and repeat the above steps to obtain the changes in the types and contents of substances in the human sample solution by measuring the lateral friction force.
[0009] The present invention provides a novel method for detecting metabolic diseases, which is also characterized by: utilizing the correlation between the wettability of the liquid and the type and content of the substances contained in the solution itself, and accurately characterizing it through the magnitude of the lateral friction force, thereby realizing the examination of human metabolic diseases when testing human samples.
[0010] The present invention provides a novel method for detecting metabolic diseases, which is also characterized in that the syringe of the microinjector has been hydrophobically treated and is used in combination with a copper superhydrophobic substrate, so that sample droplets are easier to add and changes in wettability on the superhydrophobic surface are easier to observe.
[0011] The present invention provides a novel method for detecting metabolic diseases, which is also characterized in that: the capacity of the microinjector is 10 μL, the diameter of the syringe liquid hole is 0.05 mm; and the laser is a semiconductor laser with an output laser wavelength of 700 nm.
[0012] The present invention provides a novel metabolic disease detection method, which is also characterized in that: the photoelectric position sensitive detector is a position sensitive sensor PSD.
[0013] The present invention provides a method for detecting metabolic diseases using lateral friction force, which is also characterized in that the capillary tube is a rectangular single tube with a tube length of 50 mm, a width of 1 mm, and a thickness of 0.1 mm.
[0014] Compared with the existing technology, the beneficial effects of the present invention are embodied in:
[0015] 1. This invention utilizes physical methods to detect the properties of human samples, overcoming the challenges of current biochemical detection methods, which often require a single test kit or antibody, separate sampling, and separate testing. This method is simpler to operate, lowers costs, and can more accurately and rapidly detect metabolic diseases.
[0016] 2. This invention uses mechanics to characterize changes in human sample properties, avoiding the limited detection range of existing detection methods. It also utilizes lateral friction to characterize sample properties at the microcolumn level, significantly increasing sensitivity during the characterization process.
[0017] 3. The optical path structure of the present invention is simple and easy to build. By processing the information on the computer and displaying the measurement results, the dynamic change curve of the lateral friction force of the measured sample can be obtained more intuitively and vividly, thereby accurately obtaining the changes in the relevant properties of the measured sample. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 It is an operation flow chart of the method of the present invention;
[0019] Figure 2 Schematic diagram of the detection principle in the method of the present invention;
[0020] Figure 3 It is the Lab VIEW data visualization display operation page in the method of the present invention;
[0021] Figure 4 is a calibration curve of the glucose solution sample and the lateral friction force on the copper superhydrophobic substrate in the method of the present invention;
[0022] Numbers in the figure: 1 laser, 2 capillary, 3 micro-liquid injector, 4 copper super-hydrophobic substrate, 5 photoelectric position sensitive detector, 6 data acquisition card, 7 computer. DETAILED DESCRIPTION
[0023] The present invention is described in detail below with reference to the accompanying drawings for easy understanding by technicians.
[0024] Example 1
[0025] The steps for using a new metabolic disease detection method are as follows:
[0026] First, a standard sample solution is prepared for calibration. A microinjector (3) is used to slowly squeeze out 3 μL of the standard sample solution. The droplet is kept dripping slowly from the needle of the microinjector (3) onto a copper super-hydrophobic substrate (4). The copper substrate (4) begins to move under the action of an external force. After the sample solution droplet contacts the free end of the capillary (2), the reflected light beam generated by the laser (1) is received by the photodetector (5). The lateral friction force of different standard sample solution droplets is displayed in real time on the LabVIEW program at the computer (7) through the data acquisition card (6). The relationship between different standard sample solutions and their lateral friction force is calibrated. A human sample solution to be tested is prepared and the above operation steps are repeated. The changes in the types and contents of substances in the human sample solution are obtained by measuring the lateral friction force.
[0027] Example 2
[0028] like Figure 1 A novel method for detecting metabolic diseases is characterized by comprising:
[0029] A capillary (2) is vertically cantilevered with a free end above a copper superhydrophobic surface (4);
[0030] The liquid drop in the liquid hole of the micro-injector (3) does not contact the capillary (2) in the initial state, and the light spot of the laser beam emitted by the laser (1) after being reflected by the capillary (2) coincides with the center position of the photoelectric position sensitive detector (5);
[0031] A laser (1) emits a laser beam from top to bottom at a 45° angle to the capillary (2) and generates a reflected beam at the free end of the capillary (2);
[0032] A micro-injector (3) is arranged on the left side of the free end of the capillary (2); the bottom of the micro-injector (3) is a syringe liquid hole; the sample liquid stored in the micro-injector (3) can be pushed into the syringe liquid hole by a syringe and injected onto the copper super-hydrophobic substrate surface (4);
[0033] A photoelectric position sensitive detector (5) is provided in the reflection loop of the reflected light and is used to receive the reflected light. The data acquisition card (6) transmits the output signal of the photoelectric position sensitive detector (5) obtained by the acquisition to a computer (7) for signal processing, thereby realizing accurate detection of the lateral friction force of different samples.
[0034] Based on the optical lever amplification principle, a one-dimensional photoelectric position sensitive detector (5) is used to measure the position change of the light spot reflected by the capillary (2). O(x0, y0) is the quadrant center point, O'(x0, y0) is the actual displacement of the light spot on the coordinate axis, and the relative offset of the light spot on the photoelectric position sensitive detector (5) is calculated by the following formula (1), and the bending deflection ΔZ of the capillary (2) is calculated by formula (2):
[0035] ΔS=|y1-y0|=dy (1)
[0036]
[0037] F=kΔZ (3)
[0038] dy--theoretical displacement of the light spot
[0039] ΔS--displacement of the light spot on the photosensitive target surface
[0040] ΔZ--bending deflection of capillary tube
[0041] l--capillary length
[0042] ΔL--Distance of reflected light
[0043] k - spring constant of the capillary
[0044] Then, the lateral friction force F is: F = kΔZ, and the standard sample solution is calibrated with the change in the lateral friction force. By detecting the lateral friction force of the sample solution to be tested, the type and content of the substance contained in the sample solution can be accurately obtained.
[0045] The present invention is illustrated through specific implementation processes, but these do not constitute limitations on the invention. Without departing from the spirit of the invention, various changes and modifications made to the technical solution of the invention by those skilled in the art should fall within the scope of protection determined by the claims of the invention.
Claims
1. A novel method for detecting metabolic diseases, characterized in that include: First, a standard sample solution is prepared for calibration, and the standard sample solution is slowly squeezed out using a micro-injector, and the droplets are kept dripping slowly from the micro-injector needle onto the copper super-hydrophobic substrate, and the super-hydrophobic copper substrate begins to move under the action of external force; After the sample solution droplet contacts the free end of the capillary, the reflected light beam generated by the laser is received by the photoelectric position sensitive detector, and the lateral friction force of different standard sample solution droplets is displayed in real time on the Lab VIEW program on the computer through the data acquisition card, and the relationship between different standard sample solutions and their lateral friction force is calibrated; Prepare a human sample solution to be tested and repeat the above steps to obtain the changes in the types and contents of substances in the human sample solution by measuring the lateral friction force.
2. A novel metabolic disease detection method according to claim 1, characterized in that: The capillary (2) is vertically suspended with a free end above the copper super-hydrophobic substrate (4); In the initial state, the liquid drop in the liquid hole of the micro-injector (3) does not contact the capillary (2), and the light spot of the laser beam emitted by the laser (1) after being reflected by the capillary (2) coincides with the center position of the photoelectric position sensitive detector (5); A laser (1) emits a laser beam from top to bottom along a direction at an angle of 45° to the capillary (2) to irradiate the free end of the capillary and generate a reflected light beam at the free end of the capillary (2); A micro-injector (3) is arranged on the left side of the free end of the capillary (2); the bottom of the micro-injector (3) is a syringe liquid hole; the sample liquid stored in the micro-injector (3) can be pushed into the syringe liquid hole by a syringe and dripped onto the surface of the copper super-hydrophobic substrate (4); A photoelectric position sensitive detector (5) is arranged in the reflection loop of the reflected light and is used to receive the reflected light. The data acquisition card (6) transmits the output signal of the photoelectric position sensitive detector (5) obtained by the acquisition to a computer (7) for signal processing, thereby realizing accurate detection of the lateral friction force of different samples.
3. A novel metabolic disease detection method according to claim 1, characterized in that: According to the principle of optical lever amplification, a one-dimensional photoelectric position sensitive detector is used to measure the position change of the light spot reflected by the capillary; O(x0, y0) is the center point of the quadrant, O'(x0, y0) is the actual displacement of the light spot on the coordinate axis, and the relative offset of the light spot on the detector is calculated by the following formula (1), and the bending deflection ΔZ of the micro cantilever is calculated by formula (2): ΔS=|y1-y0|=dy (1) F=kΔZ (3) dy--theoretical displacement of the light spot ΔS--Displacement of the light spot on the photosensitive target surface ΔZ--bending deflection of capillary l--length of capillary ΔL--Distance of reflected light k - spring constant of capillary Then, the lateral friction force F is: F=kΔZ, and the standard sample solution and the change in the lateral friction force are calibrated. By detecting the lateral friction force of the sample solution to be tested, the type and content of the substance contained in the sample solution can be accurately obtained.
4. A novel metabolic disease detection method according to claim 1, characterized in that: The syringe of the micro-injector (3) has been treated to be hydrophobic and is used in combination with a copper super-hydrophobic substrate (4), so that sample droplets can be added more easily and changes in wettability on the super-hydrophobic surface can be more easily observed.
5. A novel metabolic disease detection method according to claim 1, characterized in that: The capacity of the micro-injector (3) is 10 μL, and the diameter of the liquid hole of the syringe is 0.05 mm; the laser (1) is a semiconductor laser with an output laser wavelength of 700 nm.
6. A novel metabolic disease detection method according to claim 1, characterized in that: The capillary tube (2) is a rectangular single tube with a tube length of 50 mm, a width of 1 mm and a thickness of 0.1 mm.
Citation Information
Patent Citations
Kit and method for detecting related substances of genetic metabolic diseases by non-derivative tandem mass spectrometry
CN111650314A
Sampling gun integrating liquid drop sampling, sample treatment and detection and method thereof
CN113667597A
Platform droplet probe and preparation method thereof, and droplet friction force and normal force detection method
CN113686732A
Liquid drop adhesive force detection system based on micro-cantilever beam
CN114371124A
